0000000001186865

AUTHOR

M Bräutigam

showing 1 related works from this author

<tocheading>Original Article</tocheading>

1999

In this double-blind clinical trial 429 patients (217 terbinafine and 212 clotrimazole) were randomized to receive twice daily terbinafine 1% topical solution for 1 week followed by a vehicle application for 3 weeks, or 1% clotrimazole solution for 4 weeks. Patients were evaluated clinically and mycologically at baseline and then at weeks one, two, four (end of treatment), and eight (end of follow-up). To be evaluable the patient needed to have a positive culture for a dermatophyte and positive KOH microscopy and a clinical diagnosis of tinea pedis (interdigital type) at baseline. Effective treatment of tinea pedis was recorded in 181 of 217 (83%) of patients treated for 1 week with terbina…

medicine.medical_specialtybusiness.industryClotrimazoleDermatologyGeneral Medicinemedicine.disease_causemedicine.diseaseDermatologylaw.inventionClinical trialInfectious DiseasesRandomized controlled trialTolerabilitylawmedicineDermatophyteTerbinafinebusinessAdverse effectMycosismedicine.drugMycoses
researchProduct